Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jacob Lokich

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Activities & Behaviors

Drug Evaluation

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
20
Bern, MM
19
Anderson, Norwood
12
Coco, Frank
8
Dow, E
3
Moore, C
1
Hahn, Richard
1
Egorin, Merrill

Sign-in to see all Coauthors

Publications

TOP 3
Lokich Jake
Same-day pegfilgrastim and chemotherapy.
Lokich Jake
Tumor response and survival end points in clinical trials: a clinician's perspective.
Lokich Jacob
Capecitabine: fixed daily dose and continuous (noncyclic) dosing schedule.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jacob Lokich (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2005: Lokich Jake
Same-day pegfilgrastim and chemotherapy.
Cancer investigation 2005;23(7):573-6.
2004: Lokich Jake
Tumor response and survival end points in clinical trials: a clinician's perspective.
American journal of clinical oncology 2004;27(5):494-6.
2004: Lokich Jacob
Capecitabine: fixed daily dose and continuous (noncyclic) dosing schedule.
Cancer investigation 2004;22(5):713-7.
2003: Childress June; Lokich Jake
Cutaneous hand and foot toxicity associated with cancer chemotherapy.
American journal of clinical oncology 2003;26(5):435-6.
2003: Lokich Jacob; Anderson Norwood; Coco Frank
Alternating doublets: establishing the optimal multifractionated dosing schedule to administer docetaxel, cisplatin, gemcitabine, and vinorelbine in combination.
Cancer investigation 2003;21(6):830-6.
2002: Lokich Jacob
Multifractionated dosing for chemotherapy with flexible cytokine use: strategy for optimizing the therapeutic index.
American journal of clinical oncology 2002;25(1):101-2.
2002: Lokich Jacob
Diagnostic workup of neoplastic lesions in the cirrhotic liver: the case for minimizing invasive diagnostic studies.
Cancer investigation 2002;20(5-6):777-8.
1999: Lokich J J; Sonneborn H; Anderson N R; Bern M M; Coco F V; Dow E; Oliynyk P
Combined paclitaxel, cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas.
Cancer 1999;85(11):2347-51.
1999: Lokich J J; Anderson N; Bern M; Coco F; Dow E
The multifractionated, twice-weekly dose schedule for a three-drug chemotherapy regimen: a phase I-II study of paclitaxel, cisplatin, and vinorelbine.
Cancer 1999;85(2):499-503.
1999: Anderson N; Lokich J; Moore C; Bern M; Coco F
A dose-escalation phase II clinical trial of infusional mitomycin C for 7 days in patients with advanced measurable colorectal cancer refractory or resistant to 5-fluorouracil.
Cancer investigation 1999;17(8):586-93.
1999: Lokich J
Multifractionated dosing for cancer chemotherapy: a novel schedule and a work in progress.
Cancer investigation 1999;17(7):551-4.
1999: Lokich J
Single-dose granulocyte colony-stimulating factor concomitant with multifractionated dose chemotherapy: a strategy for maintaining dose intensity.
Cancer investigation 1999;17(7):547-50.
1998: Lokich J
Infusional 5-FU: historical evolution, rationale, and clinical experience.
Oncology (Williston Park, N.Y.) 1998;12(10 Suppl 7):19-22.
1998: Lokich J; Levine H; Nasser I
Malignancy-related hydrocephalus: clinical features and results of ventricular peritoneal shunt procedure in three patients.
American journal of clinical oncology 1998;21(4):366-8.
1998: Lokich J; Anderson N; Moore C; Bern M; Coco F; Sonneborn H; Dow E; Strong D
Paclitaxel, cisplatin and etoposide combination chemotherapy: a comparison of dose intensity in two multifractionated dose schemas.
European journal of cancer (Oxford, England : 1990) 1998;34(5):664-7.
1998: Lokich J; Anderson N; Bern M; Coco F; Gotthardt S; Oliynyk P; Dow E
Paclitaxel, cisplatin, etoposide combination chemotherapy: a multifractionated bolus dose schedule for non-small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1998;34(5):659-63.
1998: Lokich J; Moore C; Anderson N; Bern M; Coco F; Dow E; Zipoli T
Phase I-II trial of 14 day infusional 6-mercaptopurine in advanced colorectal cancer.
European journal of cancer (Oxford, England : 1990) 1998;34(4):584-5.
1998: Lokich J; Anderson N
Carboplatin versus cisplatin in solid tumors: an analysis of the literature.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(1):13-21.
1998: Lokich J
Incurable breast cancer and long-term survival: anecdotes toward a new paradigm.
Cancer investigation 1998;16(4):295-6.
1996: Lokich J J; Moore C L; Anderson N R
Comparison of costs for infusion versus bolus chemotherapy administration--Part two. Use of charges versus reimbursement for cost basis.
Cancer 1996;78(2):300-3.
1996: Lokich J J; Moore C L; Anderson N R
Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
Cancer 1996;78(2):294-9.
1996: Lokich J; Anderson N; Moore C; Bern M; Coco F; Dow E; Zipoli T; Gonzalves L
Pilot study of ambulatory infusional delivery of a multidrug regimen: cisplatin, 5-fluorouracil and leucovorin (PFL) +/- etoposide.
The Journal of infusional chemotherapy 1996;6(1):43-6.
1996: Lokich J; Anderson N; Moore C; Bern M; Coco F; Dow E
Pilot study of ambulatory infusional delivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE).
The Journal of infusional chemotherapy 1996;6(1):39-42.
1995: Lokich J; Anderson N; Bern M; Coco F; Dow E; Moore C; Zipoli T; Gonzalves L
Multi-day fractionated administration schedule for paclitaxel.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(9):883-5.
1994: Lokich J
Metastatic adamantinoma of bone to lung. A case report of the natural history and the use of chemotherapy and radiation therapy.
American journal of clinical oncology 1994;17(2):157-9.
1993: Anderson N R; Lokich J J; Moore C
The syndrome of 5-fluorouracil cardiotoxicity: an elusive cardiopathy.
Cancer 1993;72(7):2287-8.
1993: Lokich J J; Zipoli T E; Anderson N R; Moore C; Gonzalves L; Bern M M; Coco F
Pilot study of ambulatory infusional ifosfamide admixed with carboplatin.
Cancer 1993;71(6):2072-5.
1992: Lokich J; Anderson N; Bern M; Zipoli T; Gonsalves L; Moore C
Etoposide plus carboplatin admixture. Phase I study of five- or seven-day continuous infusion.
American journal of clinical oncology 1992;15(4):314-8.
1991: Lokich J; Anderson N; Bern M; Coco F; Zipoli T; Moore C; Gonsalves L
Dual modulation of 5-fluorouracil using leucovorin and hydroxyurea. A phase I trial.
Cancer 1991;68(4):744-6.
1991: Lokich J; Anderson N; Bern M; Zipli T; Gonsalves L; Moore C
Infusional carboplatin. Phase I studies of 5-day and 14-day infusions.
Cancer 1991;68(1):68-71.
1991: Lokich J; Moore C; Anderson N; Bern M
Infusion of floxuridine plus etoposide plus cisplatin in human malignancies.
European journal of cancer (Oxford, England : 1990) 1991;27(12):1593-6.
1989: Lokich J; Chaffey J; Neptune W
Concomitant 5-fluorouracil infusion and high-dose radiation for stage III non-small cell lung cancer.
Cancer 1989;64(5):1021-5.
1989: Lokich J; Bern M; Anderson N; Wallach S; Moore C; Beauchamp K; Williams D
Cyclophosphamide, methotrexate, and 5-fluorouracil in a three-drug admixture. Phase I trial of 14-day continuous ambulatory infusion.
Cancer 1989;63(5):822-4.
1989: Lokich J; Anderson N; Bern M; Wallach S; Moore C; Williams D
Etoposide admixed with cisplatin. Phase I clinical investigation of 72-hour infusion.
Cancer 1989;63(5):818-21.
1989: Anderson N; Lokich J; Bern M; Wallach S; Moore C; Williams D; Umprayn V
Combined 5-fluorouracil and floxuridine administered as a 14-day infusion. A phase I study.
Cancer 1989;63(5):825-7.
1989: Anderson N; Lokich J; Bern M; Wallach S; Moore C; Williams D
A phase I clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusion. Demonstration of biochemical modulation.
Cancer 1989;63(2):233-7.
1989: Lokich J J; Egorin M J; Cohen B E; Bern M M; Zipoli T E; Moore C
A phase I study of thiotepa administered by short-term and protracted continuous intravenous infusion.
Cancer 1989;63(1):46-50.
1988: Lokich J; Anderson N; Bern M; Wallach S; Moore C; Williams D; Umprain V
Combined floxuridine and cisplatin in a fourteen day infusion. Phase I study.
Cancer 1988;62(11):2309-12.
1987: Bern M M; Wallach S R; Arkin C F; Lokich J J; Huberman M S; Anderson N R; Corkery J C; Paul S D; Phillips D F; Sonneborn H A
Etoposide in combination with cytarabine, doxorubicin, and 6-thioguanine for treatment of acute nonlymphoblastic leukemia in a protocol adjusted for age.
Cancer treatment reports 1987;71(2):201-3.
1986: Lokich J; Zipoli T; Green R
Infusional cisplatin plus cyclophosphamide in advanced ovarian cancer.
Cancer 1986;58(11):2389-92.
1986: Lokich J J; Zipoli T E; Moore C; Sonneborn H; Paul S; Greene R
Doxorubicin/vinblastine and doxorubicin/cyclophosphamide combination chemotherapy by continuous infusion.
Cancer 1986;58(5):1020-3.
1986: Lokich J; Zipoli T; Greene R; Paul S; Sonnenborn H; Moore C
Protracted low-dose cisplatin infusion in advanced colorectal cancer.
Cancer treatment reports 1986;70(4):523-4.
1986: Huberman M; Lokich J; Greene R; Paul S; Phillips D; Sonneborn H; Zipoli T
Vinblastine plus cisplatin in advanced non-small cell lung cancer: lack of advantage for vinblastine infusion schedule.
Cancer treatment reports 1986;70(2):287-9.
1985: Lokich J J; Phillips D; Green R; Paul S; Sonneborn H; Zipoli T E; Curt G
5-Fluorouracil and methotrexate administered simultaneously as a continuous infusion. A phase I study.
Cancer 1985;56(10):2395-8.
1985: Lokich J J; Curt G
A phase I and pharmacology study of continuous-infusion low-dose methotrexate administration.
Cancer 1985;56(10):2391-4.
1985: Matelski H; Greene R; Huberman M; Lokich J; Zipoli T
Randomized trial of estrogen vs. tamoxifen therapy for advanced breast cancer.
American journal of clinical oncology 1985;8(2):128-33.
1985: Lokich J J; Zipoli T E; Sonneborn H; Paul S; Philips D
Streptozotocin for metastatic malignant melanoma.
American journal of clinical oncology 1985;8(1):45-6.
1984: Matelski H W; Lokich J J; Huberman M S; Zipoli T E; Paul S; Sonneborn H; Philips D
Adriamycin, cyclophosphamide, and etoposide (VP-16-213) in extensive-stage small cell lung cancer.
American journal of clinical oncology 1984;7(6):729-32.
1984: Lokich J J; Zipoli T E; Perri J; Bothe A
Protracted vinblastine infusion. Phase I-II study in malignant melanoma and other tumors.
American journal of clinical oncology 1984;7(5):551-3.
1984: Lokich J J; Zipoli T E
Phase-I study of protracted infusion of cisplatin.
Cancer drug delivery 1984;1(3):247-50.
1983: Lokich J J; Sonneborn H; Paul S; Zipoli T
Phase I study of continuous venous infusion of floxuridine (5-FUDR) chemotherapy.
Cancer treatment reports 1983;67(9):791-3.
1983: Lokich J J; Perri J; Bothe A; Zipoli T; Philips D; Sonneborn H; Paul S; Green R
Cancer chemotherapy via ambulatory infusion pump.
American journal of clinical oncology 1983;6(3):355-63.
1983: Lokich J; Fine N; Perri J; Bothe A
Protracted ambulatory venous infusion of 5-fluorouracil.
American journal of clinical oncology 1983;6(1):103-7.
1983: Lokich J; Bothe A; Zipoli T; Green R; Sonneborn H; Paul S; Philips D
Constant infusion schedule for adriamycin: a phase I-II clinical trial of a 30-day schedule by ambulatory pump delivery system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(1):24-8.
1982: Lokich J; Bothe A; Fine N; Perri J
The delivery of cancer chemotherapy by constant venous infusion. Ambulatory management of venous access and portable pump.
Cancer 1982;50(12):2731-5.
1982: Lokich J; Perri J; Fine N; Bothe A; Nelson T; Greene R; Zipoli T
Mitomycin C: phase I study of a constant infusion ambulatory treatment schedule.
American journal of clinical oncology 1982;5(4):443-7.
1981: Lokich J; Kinsella T; Perri J; Malcolm A; Clouse M
Concomitant hepatic radiation and intraarterial fluorinated pyrimidine therapy: correlation of liver scan, liver function tests, and plasma CEA with tumor response.
Cancer 1981;48(12):2569-74.
1981: Lokich J; Bothe A; Fine N; Perri J
Phase I study of protracted venous infusion of 5-fluorouracil.
Cancer 1981;48(12):2565-8.
1981: Moertel C G; Frytak S; Hahn R G; O'Connell M J; Reitemeier R J; Rubin J; Schutt A J; Weiland L H; Childs D S; Holbrook M A; Lavin P T; Livstone E; Spiro H; Knowlton A; Kalser M; Barkin J; Lessner H; Mann-Kaplan R; Ramming K; Douglas H O; Thomas P; Nave H; Bateman J; Lokich J; Brooks J; Chaffey J; Corson J M; Zamcheck N; Novak J W
Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group.
Cancer 1981;48(8):1705-10.

Sign-in to see more